Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humans

Lipids

Volumn 36, Issue 6, 2001, Pages 549-554

  Carrilho, Alexandre J F ^a   Cunha Neto, Malebranche B ^a   Nunes, Valéria S ^a   Lottenberg, Ana M P ^a   Medina, Wilson L ^a   Nakandakare, Edna R ^a   Musolino, Nina R ^a   Bronstein, Marcello D ^a   Quintão, Eder C R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRIFUGATION; DISEASES; HORMONES; PROTEINS;

LIPOPROTEINS;

PATIENT TREATMENT;

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HUMAN GROWTH HORMONE; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034894731     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0756-y     Document Type: Article

References (52)

1. Premature mortality due to cardiovascular disease in hypopituitarism
2. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults
3. Serum lipids levels in growth hormone-deficient men
4. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
5. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency
6. Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults
7. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency
8. Effect of growth hormone replacement therapy on plasma lecithin: Cholesterol acyltransferase and lipid transfer protein activities in growth hormone-deficient adults
9. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo (a) and Apo E phenotypes
10. The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: Results of a double-blind and placebo-controlled trial
11. Growth Hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
12. The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein (a) in growth hormone-deficient adults
13. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment
14. Hormonal regulation of serum lipoprotein (a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I
15. Lipoprotein(a) and coronary heart disease
16. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
17. Plasma lipid transfer proteins
18. Regulation of Cholesteryl Ester Transfer Protein (CETP) activity: Review of in vitro and in vivo studies
19. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
20. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma
21. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
22. Atherogenic diet increases cholesteryl ester transfer protein messager RNA levels in rabbit liver
23. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice
24. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: Relationship to apolipoprotein E genotype
25. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles
26. Plasma concentration of cholesteryl ester transfer protein in hyperlipoproteinemia: Relation to cholesteryl ester transfer protein activity and other lipoprotein variables
27. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia
28. Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: Plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients
29. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine
30. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors
31. LDL subfractions in acromegaly: Relation to growth hormone and insulin-like growth factor-I
32. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
33. Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (pravastatin) and cholestyramine
34. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol
35. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
36. Isolation and characterization of human plasma lipid transfer proteins
37. A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma
38. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetes and normal controls
39. 3H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma
40. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects
41. Separation of plasma lipoproteins by density-gradient ultracen-trifugation
42. Protein measurement with the folin phenol reagent
43. Phosphorus assay in column chromatography
44. Effects of normalization of GH hypersecretion on lipoprotein(a) and other lipoprotein serum levels in acromegaly
45. Two weeks of daily injections and continuous infusion of recombinant human Growth Hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity
46. In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated rat liver
47. Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipase, and cholesterol ester transfer activities in healthy young men
48. Quantification of human Plasma Phospholipid Transfer Protein (PLTP): Relationship between PLTP mass and phospholipid transfer activity
49. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tisssue by growth hormone treatment during weight loss in obese patients
50. Evidence for nonesterified fatty acid as modulators of neutral lipid transfer in normolipidemic human plasma
51. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F
52. The capacity of various non-esterified fatty acids to suppress lipid transfer inhibitor protein activity is related to their pertubation of the lipoprotein surface